Healthcare M&AI is written by Shawn Rothlis. If someone forwarded this to you and you want the full workflow - including prompts and tool recommendations - in your inbox every week: Subscribe to Healthcare M&AI at healthcaremai.beehiiv.com

My Sr. Director left on a Friday. The LOI was already signed on a transformational acquisition. I was a Manager who had just been handed a Director title and told, in so many words: you're driving this now.

The seller was unusually sophisticated for a counterparty not utilizing sell-side representation. He understood value-based care and reimbursement models in our space at a level most sellers don't, and he recognized the strategic value his locations held for our platform. He wasn't going to leave that on the table.

It was just the two of us - him and his advisors on one side, and me with our attorneys on the other. I was the one at the table for the business deal points. Not the lawyers. Me.

By the time we closed, I had found significant savings across employment agreements, lease terms, survival limits, and warranty indemnification caps - more than I expected going in. The deal almost died multiple times. And I did the whole thing without the AI tools I'm going to walk you through today.

I've thought a lot about how differently that negotiation would have gone if I'd had these workflows. That's what this issue is about.

The Problem with M&A Negotiation Prep as It's Usually Done

Standard preparation for a deal negotiation looks like this: your lawyers red-flag the purchase agreement, you build a list of open points, you walk into the room (or Zoom), and you figure it out.

That approach works. But it leaves information asymmetry on the table - the kind the other side tends to have over you.

The seller I was across from had done his homework. He knew where my platform's dependency on his locations made him hard to replace. He knew the market benchmarks on indemnification caps. He knew which of his positions were legally aggressive and which were defensible.

The goal isn't to replace the judgment you bring into the room. It's to show up with preparation that matches or exceeds the counterparty's. AI compresses prep time and surfaces issues that manual review misses. In healthcare M&A - where employment agreements, lease assumptions, indemnification provisions, and value-based care contract terms all interact - that gap in preparation is usually where money gets left.

What the AI Workflow Actually Looks Like

Three phases, sequential for a reason.

Phase 1: Document review and issue-spotting. AI tools run a first-pass analysis of the draft purchase agreement, employment agreements, and lease documents - generating structured issues lists that flag deviations from market norms. Not a replacement for legal review; a way to show up to that review already knowing where the problems are.

Phase 2: Counterparty leverage assessment. Before you take a position on any term, you should have a structured view of where the seller has leverage and where they don't. AI can build this brief from the inputs you provide - practice profile, deal structure, competitive dynamics, seller motivations. The output is a framework for understanding which of their positions are hard holds vs. anchors.

Phase 3: Concession matrix. Map every open deal point against two dimensions: cost to you if you concede, and value to the seller if you do. This four-quadrant framework becomes your negotiation playbook - what to give early, what to package if talks stall, and what to protect.

The tools that support this workflow range from purpose-built legal AI to general-purpose models, depending on the stakes and the sensitivity of the documents involved.

For purchase agreement analysis, Harvey AI is the current standard for sophisticated deal teams - PwC's alliance with Harvey has already executed over 10,000 due diligence reports on the platform. For teams that don't have Harvey, Spellbook integrates directly into Microsoft Word. For high-volume data rooms, Luminance processed 3,600 documents per hour in a documented case study vs. 79 per hour manually.

For counterparty intelligence briefs and concession modeling, Claude Enterprise or ChatGPT Enterprise are the workhorses. Perplexity AI is particularly good for pre-deal research because it synthesizes sources with verifiable citations - research has found it reduces due diligence research time by 50-70% in financial services contexts. For healthcare-specific payer contracts, Ntracts is purpose-built for payer-provider agreements and will catch change-of-control provisions that general-purpose AI misses.

Data security is non-negotiable: for actual deal documents, enterprise-tier tools only. The public versions of ChatGPT and Claude are not appropriate for uploading confidential counterparty information.

Why Healthcare M&A Is Different

Let’s take radiation oncology acquisitions for example. These types of deals have specific wrinkles that general-purpose AI frameworks don't account for by default.

Employment agreements in physician practice deals are high-stakes. The physician seller is often also your most valuable post-closing asset. Non-compete geography and duration matter for both legal enforceability and referral relationship protection. Tail insurance split is a real dollar figure. wRVU-based compensation models introduce complexity that touches both deal structure and long-term integration.

Real estate terms are disproportionately important. Radiation oncology facilities - linear accelerator vaults, shielding infrastructure - have limited alternative uses, which concentrates risk in lease terms. When the seller owns the real estate - which happens regularly in physician practice M&A - lease economics become a direct negotiating lever. AI can scan all leases simultaneously for change-of-control clauses, triple-net obligations, and renewal notice windows - things that are easy to miss across a multi-site portfolio.

Indemnification benchmarks are things most practitioners don't know cold. The ABA Private Target M&A Deal Points Study puts the median basket at 0.5% of purchase price. Caps in the lower middle market typically run 10-20%. Survival periods for general reps are 12-24 months; healthcare regulatory reps - Stark, Anti-Kickback, CMS billing - should be designated as fundamental reps with extended survival, given that the False Claims Act lookback can run 6+ years. If you don't know these numbers going in, you're negotiating blind. In my deal, the seller's opening position on survival limits and caps was aggressive. Being able to cite market benchmarks changed the conversation.

What AI Cannot Do at the Table

I want to be direct about this because I've seen the overclaiming go both ways.

When that seller paused before responding to my position on the indemnification cap, I was watching his face. When one of his advisors leaned in to say something, I was reading the room. None of that shows up in a model.

Bloomberg Law's analysis on AI in negotiations puts it well: "A contract can be reviewed in record time and still fall flat because the team missed deeper strategic signals such as the personality across the table, the unspoken priorities, or the tension hiding behind a routine objection."

In healthcare deals specifically, the physician seller is usually also the key post-closing employee and the cultural leader of the organization you're buying. A negotiation posture that wins on every term but loses the physician's trust is a bad outcome. Knowing when to slow down - when to hold a term less tightly than you legally could - is a judgment call that comes from experience in the room. AI can help you prepare. It cannot make that call for you.

From what I've seen, the practitioners who get the most out of these tools are the ones who treat AI as preparation infrastructure, not as a substitute for judgment. Show up more prepared than the other side. Know the benchmarks. Know where their leverage is soft. Know which concessions cost you little but signal a lot. Then trust your reads in the room.

The section below covers the full step-by-step workflow with specific tool recommendations and copy-paste prompts for each phase of negotiation prep. Subscriber content.

Subscribe to keep reading

This content is free, but you must be subscribed to Healthcare M&AI to continue reading.

Already a subscriber?Sign in.Not now

Keep Reading